Tensec | $12,000,000 | (Jun 19, 2025)
Grifin | $11,000,000 | (Jun 19, 2025)
Materna Medical | $20,000,000 | (Jun 19, 2025)
Certified by Founder
Lodge
Vima Therapeutics
start up
United States
- Cambridge, Massachusetts
- 30/05/2025
- Series A
- $60,000,000
Vima Therapeutics is a clinical-stage biotechnology company pioneering a new era in the treatment of dystonia and related movement disorders.
We are advancing VIM0423, a potential first-in-class oral therapy for dystonia, with the goal of helping individuals regain control of their movements by targeting the underlying cause of the disease.
Vima brings together a team of physicians, scientists, and drug developers with deep expertise in movement disorders and a shared commitment to deliver a meaningful oral therapy for patients.
- Industry Biotechnology Research
- Website https://vimatx.com/
- LinkedIn https://www.linkedin.com/company/vima-therapeutics/
NaroIQ | $6,500,000 | (Jun 19, 2025)
Polar | $9,860,072 | (Jun 19, 2025)
Darwix AI | $1,500,000 | (Jun 19, 2025)
Infinity Bio, Inc. | $8,000,000 | (Jun 19, 2025)
HydroBlok | $6,000,000 | (Jun 19, 2025)
Orange Quantum Systems | $13,742,820 | (Jun 19, 2025)
Corvia Medical, Inc. | $55,000,000 | (Jun 18, 2025)
GetZoot | $6,000,000 | (Jun 18, 2025)
AthenaHQ | $2,200,000 | (Jun 18, 2025)